MicroRNA-221/222 Confers Breast Cancer Fulvestrant Resistance by Regulating Multiple Signaling Pathways

Oncogene - United Kingdom
doi 10.1038/onc.2010.487
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

MicroRNA-221/222 Negatively Regulates Estrogen Receptor Α and Is Associated With Tamoxifen Resistance in Breast Cancer.

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2016English

Roles of microRNA-221/222 in Type 2 Diabetic Patients With Post-Menopausal Breast Cancer

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2016English

MicroRNA-587 Antagonizes 5-Fu-Induced Apoptosis and Confers Drug Resistance by Regulating PPP2R1B Expression in Colorectal Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2015English

MicroRNA-710 Regulates Multiple Pathways of Carcinogenesis in Murine Metastatic Breast Cancer

PLoS ONE
Multidisciplinary
2019English

Microrna-221 and Microrna-222 Modulate Differentiation and Maturation of Skeletal Muscle Cells

PLoS ONE
Multidisciplinary
2009English

LMTK3 Confers Chemo-Resistance in Breast Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2018English

MicroRNA-30c Inhibits Human Breast Tumour Chemotherapy Resistance by Regulating TWF1 and IL-11

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2013English

MicroRNA-221 Promotes Cisplatin Resistance in Osteosarcoma Cells by Targeting PPP2R2A

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy